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Quantitative proteomic changes in 
Lps-activated monocyte-derived 
dendritic cells: A sWAtH-Ms study
swati Arya1,2, Dagmara Wiatrek-Moumoulidis1,2, Silvia A. synowsky2, Sally L. shirran2, 
Catherine H. Botting2, Simon J. powis  1,2 & Alan J. stewart  1,2
Dendritic cells are key immune cells that respond to pathogens and co-ordinate many innate and 
adaptive immune responses. Quantitative mass spectrometry using Sequential Window Acquisition 
of all tHeoretical fragment-ion spectra-Mass spectrometry (sWAtH-Ms) was performed here to 
determine the global alterations in monocyte-derived dendritic cells (moDCs) in response to stimulation 
with lipopolysaccharide (LPS). A moDC library of 4,666 proteins was generated and proteins were 
quantified at 0, 6 and 24 h post-LPS stimulation using SWATH-MS. At 6 h and 24 h post-LPS exposure, 
the relative abundance of 227 and 282 proteins was statistically significantly altered (p-value ≤ 0.05), 
respectively. Functional annotation of proteins exhibiting significant changes in expression between 
the various time points led to the identification of clusters of proteins implicated in distinct cellular 
processes including interferon and interleukin signalling, endocytosis, the ER-phagosome pathway 
and antigen-presentation. In SWATH-MS major histocompatibility complex (MHC) class I proteins were 
highly upregulated at 24 h, whilst MHC class II proteins exhibited comparatively fewer changes over this 
period. This study provides new detailed insight into the global proteomic changes that occur in moDCs 
during antigen processing and presentation and further demonstrates the potential of sWAtH-Ms for 
the quantitative study of proteins involved in cellular processes.
Tissue-resident immature dendritic cells (DCs) exhibit a very high capacity to capture exogenous and cellu-
lar antigens through endocytosis and phagocytosis upon engagement of surface receptors. Antigens are recog-
nized through pattern recognition receptors including the toll like receptor (TLR) family1. Immature DCs are 
highly phagocytic, however their antigen presenting ability is very limited. After antigen recognition, immature 
DCs begin a maturation process which can be divided into five phases2. Firstly, the morphology of DCs changes 
whereby the cells grow and develop cytoplasmic projections, a process involving cytoskeleton rearrangement. 
In this first phase cell motility increases by the loss of adhesive molecules3. In the second phase, maturing DCs 
express T-cell co-stimulatory molecules on the cell surface4. The third phase is characterized by migration to 
the lymph nodes and spleen, which enables cells to enter lymphatic vessels5. In the fourth phase, DCs express 
major histocompatibility complex (MHC) class II antigen presenting molecules on their cell surface and in 
the final phase chemokines and cytokines are secreted4. At this point, DCs become fully mature and are lim-
ited in their ability to take up new antigens but are ready to present the processed antigens to chemo-attracted, 
antigen-specific T-cells to therefore initiate the immune response6. Overall DCs are considered as mature when 
they can activate T-cells through distinct mechanisms.
To provide insight into the cellular mechanisms driving DC maturation a number of studies have been 
carried out examining proteomic changes that occur in DCs during this process. Several of these studies have 
utilized electrophoresis-based protein separation techniques, such as 2D-gel electrophoresis coupled with pro-
tein identification using mass spectrometry-based approaches7–10. More recently, approaches such as MudPIT 
(multi-dimensional protein identification technology) have been used4. These DC proteomic studies have focused 
on whole cell lysates, whilst others have examined DC-derived exosomes11,12 and secretomes13. Such studies have 
provided some insight into the proteomic changes occurring in DCs during the maturation process. However to 
date, such analyses have been largely qualitative in nature and have only been able to reliably examine a relatively 
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small subset of DC proteins at a time. Also, individual proteins that exhibit altered expression profiles differ 
greatly between the described reports, with only few proteins in common, limiting the interpretation of the 
obtained data.
Here we use sequential window acquisition of all theoretical fragment ion spectra mass spectrometry 
(SWATH-MS), which uses LC-MS/MS for label-free quantitation to describe global proteomic changes in 
monocyte-derived DCs (moDCs) up to 24 h following lipopolysaccharide (LPS)-induced (TLR4-mediated) mat-
uration. Furthermore, we relate observed proteomic changes to specific cellular pathways. The presented data 
provides a high degree of quantitative information as to the proteomic and mechanistic changes that occur in 
moDCs during antigen processing and presentation.
Results
Quantitative analysis of the moDC proteome. Monocytes, 90–95% CD14+ prior to addition of IL-4 
and GM-CSF (not shown), were isolated from blood samples as described in Materials and Methods and differ-
entiated into moDCs14. The activation of dendritic cells was assessed using flow cytometry, where the presence 
of the DC maturation marker, CD8315 was confirmed in moDCs from three samples treated with 100 ng/ml LPS. 
In each case a similar average mean fluorescence upregulation of 3.1-fold was observed following the treatment 
(Figure S1). In order to generate a spectral library (for use as a reference library to match peptide fragmentation 
spectra generated in SWATH MS), data-dependent acquisition analysis of the proteomes of untreated moDCs 
(0 h) and moDCs treated with LPS for 6 and 24 h was performed. This resulted in a reference spectral library con-
sisting of 4,666 proteins with 1% false discovery rate (FDR). To determine the LPS-activation induced changes 
in the moDC proteome, we quantified the proteins treated with LPS at 0, 6 and 24 h by SWATH-MS. To increase 
the reliability of our study, proteins quantified based on 2 or more peptides were exclusively selected, this led to 
selection of 3,494 proteins, relative abundance (denoted by average peak intensity in Table S1) of which were 
compared at 6 h vs 0 h, 24 h vs 0 h and 24 h vs 6 h. Volcano plots of all 3494 proteins displaying differences in 
relative abundance at 6 h vs 0 h, 24 h vs 0 h and 24 h vs 6 h are shown in Fig. 1A–C, respectively. Of the 3494 
proteins consistently quantified during the time course, the relative abundance of a total of 227 (6.5%) proteins 
was significantly altered (p-value ≤ 0.05) 6 h after LPS treatment. More profound changes in the proteome were 
detectable 24 h after LPS treatment, where 287 unique proteins (8.2%) significantly changed (p-value ≤ 0.05). 
Between 6 h and 24 h a total of 273 unique proteins (7.8%) were significantly changed (p-value ≤ 0.05). Figure 1D 
shows a heat-map based on z-score (derived from the log2 relative abundance) of the total 243 proteins that were 
significantly altered (p-value ≤ 0.05) by at least 1.5-fold (up or down-regulated) between two of the three time 
points examined. A post-hoc estimation of FDR (q-value/adjusted p-value) for each of these proteins was addi-
tionally performed using Benjamin Hochberg correction. The quantitative information for all 3,494 proteins at 
peptide level is provided in Table S1. The quantitative value for each unique peptide originates from summing 
the integrated area of the selected b and y-ions for this peptide and is an average value for each genotypic group 
(indicated as average peak intensity). All proteins exhibiting statistically significant changes in relative abundance 
(p-value ≤ 0.05) at 6 h vs 0 h, 24 h vs 0 h and 24 h vs 6 h are listed in Tables S2–S7.
For further functional analysis of differentially regulated proteins, a fold-change cut-off of >1.5-fold was 
chosen. The SWATH-MS analysis identified 57 proteins that display >1.5-fold change in relative cellular abun-
dance 6 hours after LPS-treatment and 40 proteins were shown to exhibit >1.5-fold reductions (relative change of 
0.666) in relative cellular abundance 6 hours after LPS-treatment. Eighty seven proteins were identified to display 
>1.5-fold change in relative cellular abundance 24 hours relative to 0 h, after LPS-treatment and 46 proteins were 
shown to exhibit >1.5-fold reductions in relative cellular abundance 24 hours after LPS-treatment. Seventy five 
proteins were identified to display >1.5-fold change in relative cellular abundance 24 hours relative to 6 h, after 
LPS-treatment and 39 proteins were shown to exhibit >1.5-fold reductions in relative cellular abundance 24 hours 
after LPS-treatment.
In addition to the quantitative proteomic analysis, to gain insight into the potential changes in overall protein 
synthesis at different stages of the maturation process, protein synthesis in moDCs was measured in cells at 0 h, 
6 h, 14 h and 24 h after LPS-treatment using the Click-iT HPG assay kit (Fig. 2). Protein synthesis was found to 
increase by 58% after 14 hours (p ≤ 0.05) relative to the 0 h control. Synthesis was 32% higher than the control 
after 6 h but this increase was not deemed to be statistically significant. After 24 h protein synthesis was 43% 
higher than the control (p < 0.05). The difference in protein synthesis observed between 14 h and 24 h was not 
found to be statistically significant.
Functional annotation of differentially expressed proteins. Pathway analysis and protein interaction 
networks for moDC proteins displaying >1.5-fold change; between the respective time points (0 h, 6 h and 24 h) 
were analysed using the Reactome Pathway Database (https://reactome.org)16,17 and by Search Tool for Recurring 
Instances of Neighbouring Genes (STRING) software (https://string-db.org/)18, respectively. The Reactome path-
way analysis is an over-representation analysis that statistically determines whether proteins from certain path-
ways are enriched in the data. This analysis produces a probability score, which is corrected for FDR using the 
Benjamani-Hochberg method. A summary of the resultant data is shown in Table 1, which details the top 25 
pathways ranked by lowest p-value that are upregulated at 6 h relative to 0 h (representing early cellular processes) 
and at 24 h relative to 0 h (later cellular processes) after LPS stimulation. The full dataset displaying all pathways 
where the p-value is p < 0.05 for both up- and downregulated proteins (>1.5-fold change) and the respective 
proteins associated with each can be found in Table S8. Interaction networks for moDC proteins exhibiting the 
highest degree of significant change (>1.5-fold; p ≤ 0.05) between the respective time points (0 h, 6 h and 24 h) 
were created using STRING software. STRING is a database of known and predicted protein-protein interactions 
including direct and indirect associations. Figures S2–4 show all 6 protein interaction networks corresponding to 
up- or down-regulated proteins between the respective time points (0 h, 6 h and 24 h).
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Changes in cytokines and cytokine-induced proteins in LPS-stimulated moDCs. It was apparent 
from the pathway analyses that a number of moDC proteins associated with cytokine signalling and in particular, 
interferon and interleukin signalling had increased in expression following LPS treatment over the time course. 
Quantitative data relating to key proteins implicated in these pathways are shown in Fig. 3. The relative abundance 
of the cytokine, IL-1β was dramatically increased 21.7-fold) at 6 h post-treatment, but decreased after 24 h. A num-
ber of known interferon-responsive proteins were found to exhibit large increases in expression over the course of 
the experiment, particularly in the period up to 6 h post-stimulation. These included guanylate-binding proteins 
GBP5, interferon-induced GTP-binding proteins, Mx1 and Mx2, interferon-induced proteins with tetratricopep-
tide repeats, IFIT2, IFIT3 and interferon-stimulated gene proteins, ISG-15 and ISG20. The related OASL protein, 
exhibited a 9-fold increase in relative abundance at 6 h and remained highly expressed, albeit at slightly lower 
levels at 24 h (6-fold relative to 0 h control). The interferon-responsive ubiquitin-conjugating enzyme, UB2L6 
Figure 1. Quantitative proteomic analysis of LPS-mediated moDC maturation over a 24 h period.  
(A–C) Volcano plots of all quantified proteins displaying differences in relative abundance at 6 h vs 0 h, 24 h vs 
0 h and 24 h vs 6 h, respectively. The plot represents the -log10 of the p-value against the log2 of the fold change 
(FC). The green dots represent proteins with p-value ≤ 0.05 and log2 fold-change > 0.5. Red dots represent 
proteins with q-value ≤ 0.2 and log2 fold-change >0.5. D. Heat map representing the z-score derived from the 
log2 relative abundance of the total 243 proteins that were significantly up or down-regulated (p-value ≤ 0.05)  
by >1.5-fold between any two of the three time points (0 h, 6 h or 24 h) examined.
4Scientific RepoRts |          (2019) 9:4343  | https://doi.org/10.1038/s41598-019-40773-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
exhibited 1.6 and 3.5-fold increases in expression after 6 and 24 h, respectively. The cytokine-responsive cytoskel-
etal protein, fascin (FSCN1) underwent a large increase in expression (7.7-fold) between 6–24 h.
Changes in endocytic/phagocytic and MHC proteins in LPS-stimulated moDCs. For extracellular 
antigens to be processed prior to presentation by MHC molecules they must first enter the cell via an endocytic 
or phagocytic mechanism. Reactome pathway analysis revealed 4 proteins involved in clathrin-mediated endo-
cytosis, to be upregulated by >1.5-fold early in the maturation process (by 6 h post LPS-stimulation). These 
were signal transducing adapter molecule 2 (STAM2), disabled homolog 2 (DAB2), COP 9 signalosome complex 
subunit 8 (CSN8) and myc box-dependent-interacting protein 1 (BIN1). Three of which, STAM2, DAB2 and 
CSN8, are involved in cargo recognition. Later in the maturation process it was revealed that 5 proteins involved 
in ER-phagosome recycling were upregulated at 24 h relative to 6 h. These proteins were proteasome subunit beta 
type-9 (PSB9), beta-2-microglobulin (B2MG), tyrosine protein kinase BTK (BTK) and the two MHC I mole-
cules, HLA class I histocompatibility antigens B-44 alpha chain and Cw-3 alpha chain (1B44 and 1C03, respec-
tively). Contrary to this, it appeared that a number of proteins associated with MHC class II antigen presentation 
decreased between 6 h and 24 h. An examination of all MHC proteins detected and quantified by SWATH-MS 
revealed data pertaining to two MHC I proteins (those indicated above) and eleven MHC II proteins (Fig. 4A). 
When compared to the levels present in the 0 h control, both MHC I proteins detected and quantified (1B44 and 
1C03) were found to be significantly more abundant 24 h after treatment (by 3.9-fold and 3.7-fold vs 0 h control, 
respectively), having undergone the largest increase in expression between 6 h to 24 h. Of the eleven MHC II 
proteins detected and quantified none exhibited any particularly large changes in relative abundance at 6 h or 
24 h after LPS treatment relative to the 0 h control, although most displayed modest reduction at 24 h relative 
to 6 h. To further examine changes in expression of MHC proteins, Western blots were performed on moDC 
extracts following 0, 6, 12 and 24 h of LPS treatment using antibodies that specifically recognized MHC class 
I and MHC class II molecules, as well as β-actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as 
loading controls (Fig. 4B). A densitometric analysis of the resultant bands revealed that the collective expression 
of MHC class I molecules significantly increased over the course of the experiment (>2-fold), whilst MHC class 
II expression remained relatively constant (Fig. 4C).
Discussion
This study is the first to use SWATH-MS to quantify global proteomic changes occurring in moDCs during 
LPS-stimulated maturation. In this study 3,494 cellular proteins (which were quantified based on 2 or more pep-
tides) were analysed at 0 h, 6 h and 24 h after stimulation. Collectively, the results agreed with and vastly built 
upon other proteomic studies focussed on moDC maturation. For example, previously, using a shotgun proteom-
ics approach, Gundacker et al. identified potential changes in 22 moDC proteins (based on the relative number 
of peptides per protein) in response to LPS after 24 h13. Of these 22 proteins, 11 were also shown in our study to 
display statistically significantly increased relative abundance in moDCs and many of these (such ISG20, ISG15, 
Mx2, Mx1, IFIT2, IFIT3, ICAM1 and GBP1) were among those that exhibited the greatest increases in relative 
cellular abundance after 24 h. More recently, Strasser et al. carried out a study examining proteomic changes in 
moDCs treated with LPS as well as birch pollen allergens for 8 h and compared differences in protein expres-
sion between treatments19. In their study they used high-performance liquid chromatography and tandem mass 
Figure 2. Protein synthesis in LPS-treated moDCs. Protein synthesis was measured using the Click-iT HPG 
assay kit and results were expressed relative to control (0 h) cells. Error bars represent ± S.E.M. Statistical 
significance was assessed by t-test (ns: no significant change; *p < 0.05; n = 3).
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Protein group Pathway name
Entities
Found p-value FDR
Up-regulated; 6 h vs 0 h
Interferon signaling 10/284 2.08E-06 6.69E-04
Cytokine signaling in the immune system 15/771 7.26E-06 0.001
Interferon α/β signalling 6/137 8.35E-05 0.009
Interleukin-1 processing 2/7 6.45E-04 0.031
DDX58/IFIH1-mediated induction of Interferon-α/β 4/77 7.34E-04 0.031
ISG15 antiviral mechanism 4/78 7.70E-04 0.031
Antiviral mechanism by IFN-stimulated genes 4/78 7.70E-04 0.031
Negative regulators of DDX58/IFIH1 signaling 3/34 7.86E-04 0.031
Clathrin-mediated endocytosis 4/139 0.006 0.215
TRAF6-mediated endocytosis 2/24 0.007 0.229
Termination of translesion DNA synthesis 2/32 0.012 0.278
Cargo recognition for clathrin-mediated endocytosis 3/99 0.015 0.278
Biosynthesis of aspirin-triggered D-series resolvins 1/3 0.016 0.278
Immune system 19/2226 0.016 0.278
Translesion synthesis by Y family DNA polymerases bypasses lesions 
on DNA template 2/39 0.018 0.278
Interleukin-4 and interleukin-13 signaling 3/111 0.021 0.278
Transcriptional activation of cell cycle inhibitor p21 1/4 0.021 0.278
Biosynthesis of E-series 18®-resolvins 1/4 0.021 0.278
Biosynthesis of D-series resolvins 1/4 0.021 0.278
Interleukin-10 signaling 2/45 0.023 0.278
PKMTs methylate histone lysines 2/47 0.025 0.278
Biosyntheis of E-series 18(S)-resolvins 1/5 0.026 0.278
DNA damage bypass 2/49 0.027 0.278
Synthesis of 15-eicosatetraenoic acid derivatives 1/6 0.031 0.278
Up-regulated; 24 h vs 6 h
Antigen presentation: Folding, assembly and peptide loading of class 
I MHC 50/93 1.11E-16 4.22E-15
Endosomal/vaculolar pathway 50/79 1.11E-16 4.22E-15
Interferon signaling 63/284 1.11E-16 4.22E-15
Interferon gamma signaling 54/172 1.11E-16 4.22E-15
Class I MHC mediated antigen processing and presentation 54/440 1.11E-16 4.22E-15
ER phagosome pathway 52/152 1.11E-16 4.22E-15
Interferon α/β signaling 57/137 1.11E-16 4.22E-15
Antigen processing-cross presentation 52/168 1.11E-16 4.22E-15
Immuno-regulatory interactions between a lymphoid and a non-
lymphoid cell 51/297 1.11E-16 4.22E-15
Cytokine signaling in immune system 68/771 1.11E-16 4.22E-15
Adaptive immune system 56/944 1.11E-16 4.22E-15
Immune system 72/2226 1.11E-16 4.22E-15
DAP12 interactions 5/46 1.92E-04 0.007
TBC/RABGAPs 4/45 0.002 0.057
Antiviral mechanism by IFN-stimulated genes 5/78 0.002 0.057
ISG15 antiviral mechanism 5/78 0.002 0.057
Interleukin-9 signaling 2/9 0.005 0.124
Interleukin-21 signaling 2/10 0.006 0.147
Defective GALE can cause epimerase-deficiency galactosemia (EDG) 1/1 0.011 0.247
Defective SLC27A4 causes ichtyosis prematurity syndrome 1/1 0.011 0.247
Interleukin-6 signaling 2/15 0.013 0.267
Signaling by SCF-KIT 3/44 0.014 0.273
The NLRP inflammasome 2/16 0.014 0.273
Signalling by cytosolic FGFR1 fusion 2/18 0.018 0.341
Signaling by PDGF 3/59 0.03 0.487
Table 1. Summary of Reactome pathway analysis data for MoDC proteins exhibiting statistically significant 
increases >1.5-fold at 6 h vs 0 h and at 24 h vs 6 h. The data indicates the pathway, number of proteins found/
number of proteins in the pathway, p-value and FDR. The top 25 pathways are shown with proteins in each 
group ranked by p-value (lowest first).
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spectrometry (HPLC-MS/MS) following isobaric labelling of the samples for proteomic quantification. Whilst 
their specific study question was different from ours, they were able to identify expression of a large number of 
proteins also observed in our study.
Pathway analysis of proteins exhibiting >1.5-fold changes in relative abundance between the different time 
points (0 h, 6 h and 24 h) revealed clusters of related proteins involved in specific cellular pathways and functions. 
Of all proteins that significantly changed at 24 h relative to 0 h, ~39% displayed a decrease in relative abundance. 
This suggests that reducing the degree to which all but essential proteins and compounds are synthesized appears 
to be a strategy the cell uses to reduce its metabolic burden. Generally, fewer interactions were observed between 
decreasing proteins in the respective STRING analyses for proteins that increased in relative abundance between 
the three respective time points compared to increasing proteins. Reactome pathway database for these decreas-
ing proteins (>1.5-fold reduction) led to significant pathway hits, which varied between time points (although 
these tended to have higher FDR and p-values compared with the corresponding upregulated protein results). 
Early in the maturation process (0 h to 6 h) it was found that pathways related to mitochondrial protein import 
and cristae formation as well as synthesis of phosphatidylinositol phosphates at the endosomal membrane were 
among the most significant hits. Later in the maturation process (between 6 h to 24 h) the most significant down-
regulated pathway was MHC class II antigen presentation, reflecting the observed reductions in relative abun-
dance of MHC II molecules over this period.
In the first 6 h after LPS-mediated activation the most significant pathways identified for upregulated pro-
teins related to cytokine (interferon and interleukin) signalling, endocytosis and the synthesis of resolvins, lipid 
mediators that promote restoration of function after inflammation. Between 6 h to 24 h after LPS stimulation, 
representing a later stage in the moDC maturation process, pathways associated with antigen-presentation were 
among the most significant hits. Over this period, pathways associated interferon signalling (α/β and γ-associated 
subtypes) were significantly upregulated (FDR = 4.22 × 10−14) as were interleukin signalling pathways.
The cytokine which displayed the greatest degree of change in response to LPS was IL-1β, which exhibited 
a 22-fold increase in relative abundance by 6 h, in agreement with other studies20,21. STRING analysis revealed 
IL-1β, a key initiator of several pathways early in the dendritic cell maturation process, to be a central protein 
in the interaction network through linking to proteins involved in signal transduction and cellular responses to 
(oxidative) stress. A key cluster in the STRING network stemming from IL-1β is a group of proteins involved in 
interferon signalling, which linked to (most likely due to direct activation of) various clusters of proteins. One 
such cluster contained proteins involved in protein synthesis, which include ribosome biogenesis regulatory pro-
tein homolog (RRS1) and elongation factor Tu GTP-binding domain-containing protein 1 (ETUD1). This was 
potentially in agreement with the observation that protein synthesis in LPS-stimulated moDCs increased over 
the first 14 h. After 24 h of LPS treatment, the relative cellular abundance of IL-1β in moDCs was found to drop 
to almost basal levels, suggesting that essentially all of what is synthesized by 6 h is released and/or degraded 
over this period. IL-1 cytokines are secreted by the non-classical secretory pathway and require to be released by 
independent signals. Treatment of bone marrow-derived DCs with LPS and ATP has been shown to trigger IL-1β 
secretion via the P2X7 receptor22. Cytosolic IL-1 proteins have been shown to undergo ubiquitination, which was 
previously demonstrated to be a central mechanism for the regulation of intracellular IL-1 levels23. Consistent 
with this, >1.5-fold increases in the expression of ubiquitin function-related enzymes, UB2L6 (ubiquitin conju-
gating enzyme E2 L6) and UBA5 (ubiquitin-like modifier activating enzyme 5) were observed between 6 h and 
24 h after LPS stimulation.
IFN-αβ is known to be produced by DCs, while IFN-γ is an established autocrine mediator of DC maturation 
and is produced and secreted by LPS-stimulated bone marrow-derived DCs within 24 h of activation24. Over the 
course of the 24 h after LPS treatment the relative abundance of multiple proteins involved in cytokine/interferon 
Figure 3. LPS-induced changes in moDC proteins associated with cytokine signaling. Comparison of the 
relative fold-changes in cellular abundance of cytokine signaling proteins in moDCs at 6 vs 0 h and 24 h vs 6 h 
post-LPS stimulation as measured by SWATH-MS. Error bars represent ± S.E.M.
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signal transduction were found to change in moDCs. The SWATH-MS analysis was unable to verify expression of 
IFNs directly but revealed profound increases in the expression of various IFN-responsive proteins, particularly 
between 6 and 24 h post stimulation. Microarray studies have previously identified up to 1,000 IFN-sensitive 
genes, with 200–500 genes typical of many cell types25–27. Many of these proteins function to inhibit the multipli-
cation of viruses by inhibiting viral DNA replication28; these include interferon-induced binding proteins Mx1, 
interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), guanylate binding protein 5 (GBP5) and 
2′-5′-oligoadenylate synthase-like enzyme, which were observed in this study to display increased expression in 
moDCs in response to LPS stimulation.
For moDC-associated antigen-processing to occur, cellular detection and endocytic/phagocytic entry of 
antigen into the cell is required prior to presentation by MHC-II molecules (or cross-presentation by MHC-I 
molecules). In our study a number of endocytic proteins including cargo-recognition proteins were found to be 
upregulated following LPS stimulation, particularly by 6 h, consistent with endocytic/phagocytic entry of antigen 
into the cell. Later in the maturation process LPS-stimulation led to relative increases in ER-phagosome path-
way proteins and MHC I proteins in moDCs after 24 h (as was reflected in the pathway analyses for upregulated 
proteins at 24 h relative to both 0 h and 6 h). The ER-phagosome pathway is a mechanism moDCs use where part 
of the ER membrane is recruited to the cell surface and fuses with the plasma membrane. Underneath this por-
tion of the membrane are phagocytic cups, which are thought to supply membrane for the formation of nascent 
phagosomes29. MHC I molecules generally present peptides that are derived from endogenous proteins present 
in the cytosol but in some DC sub-types (including moDCs) they can cross-present extracellular antigens30,31. 
LPS-stimulation had a comparatively modest effect on the expression of MHC II molecules in moDCs, inducing 
only negligible differences in expression (<1.2-fold) in the MHC II proteins detected. No difference in band 
intensity could be seen by Western blotting when using an antibody that recognizes MHC II proteins. However, 
consistent with our data, it is thought that at steady state, the rate of generation of MHC II-peptide complexes 
in immature DCs is approximately equal to the rate of their degeneration32,33, with their exposure at the plasma 
membrane regulated by ubiquitination32,34.
LPS-mediated moDC cell maturation is known to induce a change in cellular morphology, characterized an 
increase in filamentous actin and the appearance of veils in mature cells35. This change in morphology becomes 
evident in cultured moDCs by 6 h, and continues beyond 24 h after LPS-stimulation35, this was also supported 
by another study which showed that LPS-induced maturation leads to robust upregulation of the actin-bundling 
protein, fascin36. In accordance with these reports, proteins related to filamentous actin assembly were found 
to be differentially expressed in our SWATH-MS study. Fascin (FSCN1) increases greatly between 6 h and 24 h 
post-LPS treatment. Similarly, cytoplasmic actin (ACTB) increases by 1.5-fold at 6 h and remains around this level 
at 24 h. It has already been demonstrated that the F-actin network in LPS stimulated dendritic cells, regulates the 
lateral mobility of intercellular adhesion molecule 1 (ICAM1)37. Interestingly, intercellular adhesion molecule 1 
(ICAM1) was consistently upregulated upon LPS-stimulation at 6 h and 24 h relative to the 0 h control. Whilst 
there were some differences in the observed expression of actin cytoskeletal regulatory proteins, very little change 
Figure 4. LPS-induced changes in endocytic/phagocytic and MHC proteins in moDCs. (A) Comparison of  
the relative fold-change in cellular abundance of endocytic/phagocytic and MHC proteins in moDCs at 6 vs 0 h 
and 24 h vs 6 h post-LPS stimulation as measured by SWATH-MS. Error bars represent ± S.E.M. (B) Western 
blot showing relative changes in MHC I and II proteins in moDCs between 0–24 h after LPS stimulation.  
(C) Quantification of MHC I and II proteins based on densitometry analysis of bands in (B). Protein levels were 
calculated relative to the 0 h control. Error bars represent ± S.E.M. Statistical significance was assessed by t-test 
(ns: no significant change; **p < 0.01; ***p < 0.001; ****p < 0.0001; n = 3).
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was observed in proteins related to tubulin assembly. Over the course of the 24 h after stimulation there were 
modest increases in tubulin beta-8 chain (TBB8), tubulin-folding cofactor B (TBCB) and gamma-tubulin com-
plex component 3 (GCP3) at various points but all of which were of a lower fold-change than our cut-off for 
cluster analysis by Reactome/STRING.
In conclusion, this study further supports SWATH-MS as a robust technology for the quantitative study of 
proteins involved in cellular processes, such as is demonstrated here for pathogenic stimulation of moDCs. The 
data presented provides the most detailed insight into the proteomic changes that occur during moDC matura-
tion to date and greatly builds on previous proteomic studies. LPS-mediated activation was found to lead to a 
significant change in the relative cellular abundance of around 14.5% of quantified moDC proteins. Specifically, 
relative abundance of proteins involved in interferon and interleukin signalling, endocytosis, the ER-phagosome 
pathway and antigen-presentation are significantly altered in the moDCs following LPS stimulation. The upreg-
ulation of proteins that contribute to these pathways is characterized by an observable corresponding increase in 
protein synthesis during the same period. We believe that this dataset will provide as a useful resource to others 
interested in the study of DCs and other antigen-presenting cells.
Materials and Methods
Ethical approval and informed consent. This study was approved by the School of Medicine Ethics 
Committee, University of St Andrews. In all cases blood samples were taken after obtaining written informed 
consent from the donors or from commercially obtained buffy coat preparations, as indicated. All methods out-
lined were performed in accordance with the relevant ethical guidelines and regulations.
Culture of monocyte-derived DCs. For flow cytometry experiments, blood was collected from two 
healthy donors and one commercial buffy coat donor. For SWATH-MS, blood was obtained from four healthy 
donors and pooled in various combinations to form three biological replicates. Samples were purified over a ficoll 
gradient at room temperature to isolate peripheral blood mononuclear cells (PBMCs; Histopaque, Sigma-Aldrich, 
Poole, UK). PBMCs were plated for 30–60 mins, non-adherent cells removed and the remaining monocytes differ-
entiated into moDCs as described previously using IL-4 and GM-CSF14. The moDCs were treated with 100 ng/ml 
of bacterial LPS (Sigma-Aldrich), or left untreated as control. Cells were cultured in sterile RPMI containing 10% 
fetal calf serum for up to 24 h.
Flow cytometry. To examine expression of the moDC maturation marker, CD83, moDCs were stimulated 
with 100 ng/ml LPS for 24 hours and stained with mouse anti-human CD83 antibody (Serotec MCA1582F). 
Analysis was performed using a Guava 8HT flow cytometer (Merck-Millipore UK) running GuavaSoft 2.7 
software.
Cell lysis and protein quantification. Cells were washed on ice with phosphate buffered saline (PBS) and 
lysed for 30 min at 55 °C with 300 µl of lysis buffer (10 mM Tris-Cl, 150 mM NaCl, 0.5% Rapi Gest, pH 7.9). Cells 
were further lysed by passaging through a syringe. Cell debris was removed following centrifugation and the 
resultant proteins were quantified using the bicinchoninic acid (BCA) protein assay kit (Thermo Fisher Scientific, 
Perth, UK).
Experimental design and statistical rationale for SWATH-MS. This experiment uses untreated den-
dritic cells (0 h) as control samples for basal protein expression levels. Experiments were performed in biological 
triplicate. To account for the probability of minor sample variability due to multiple steps in sample processing, 
one sample at each time point was ran as a technical replicate. A principal component analysis of the technical 
replicates showed excellent agreement between the resultant datasets (Figure S5). A sample-specific library was 
made by pooling all conditions for best sample representation.
Sample preparation for mass spectrometry. Two sets of tryptic digests of samples were prepared: Set 
1 (library) consisted of 170 μg of each protein sample combined to yield 1500 µg of protein to be further fraction-
ated by strong cation exchange (SCX) chromatography and high pH reversed phase chromatography. In Set 2, 
30 μg of each sample was digested separately for SWATH analysis. The same digestion procedures were carried 
out on all samples (the combined set 1 and the individual samples in set 2). To denature the protein, a stock 
solution of 10 M urea in 50 mM ammonium bicarbonate was prepared and used to adjust all samples to a final 
concentration of 5 M urea. Proteins were reduced and alkylated with 5 mM tris (2-carboxyethyl) phosphine fol-
lowed by 5 mM iodoacetamide. The reaction was quenched with 10 mM dithiothreitol. Samples were diluted with 
50 mM ammonium bicarbonate to a final urea concentration of 1.5 M. The resulting samples were then digested 
with trypsin (1:50 ratio (w/w), 0.2 µg/μl trypsin; Promega, Southampton, UK), overnight at 30 °C. To stop the 
digestion, 0.5% (v/v) trifluoroacetic acid (TFA) was added. Peptides were desalted using a C18 SepPak cartridge 
(Waters, Elstree, UK) and the solvent removed using a SpeedVac (Thermo Fisher Scientific).
LC-ESI-MSMS analysis for spectral library generation. Once re-dissolved in 1 ml of 10 mM ammo-
nium formate, 25% acetonitrile (MeCN), pH 3.0, 800 μg of peptides from the combined sample (set 1) were 
fractionated by SCX chromatography on a PolySulfoethyl A column (2.1 mm × 200 mm, 5 µm, 200 Å pore size, 
PolyLC). The column was washed with 100% Buffer Ascx (10 mM ammonium formate, 25% MeCN, pH 3.0) at 
1 ml/min for 22 min. A linear gradient of 0–50% Bscx (500 mM ammonium formate, 25% MeCN, pH 3.0) was 
applied over 20 min, 50–100% Bscx over 3 min, followed by 100% Bscx for a further 3 min to wash the column, 
before re-equilibration in 100% Ascx for another 11 min. Fractions of 0.5 ml were collected every 30 s. The UV 
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chromatogram was inspected and fractions pooled to give 7 fractions across the elution profile. The pooled frac-
tions were dried and dissolved in 0.1% formic acid (FA). They were desalted on C18 spin columns (PepClean C18 
spin columns, ThermoScientific) using the manufacturer’s instructions, eluting in 60 μl 70% MeCN/0.5% TFA. 
The elution solvent was removed in a SpeedVac and the fractions resuspended in 20 μl 0.1% FA prior to mass 
spectrometric analysis.
For high pH reversed phase fractionation, 650 µg of peptides (remainder of set 1) were resuspended in 100 µl 
Buffer A, consisting of 10 mM ammonium formate, 2% MeCN, pH 10.0. Peptides were then fractionated on a 
XBridge C18 column (4.6 × 100 mm, 5 µm, Waters) at 1 ml/min with the following gradient: linear gradient of 
4–28% Buffer B (10 mM ammonium formate, 90% MeCN, pH 10.0) for 36 min, then 28–50% B for 8 min, followed 
by 100% B for a further 5 min to wash the column, before re-equilibration in 100% A for 10 min. Fractions of 0.5 ml 
were collected every 30 s. The UV chromatogram was inspected and fractions pooled to give 10 fractions across 
the elution profile. The pooled fractions were dried and resuspended in 0.1% FA for mass spectrometric analysis.
For spectral library generation, each SCX fraction (1/3 of vol) and each high pH reversed phase fraction (1/3 of 
volume) were analysed individually on a Sciex TripleTOF 5600+ system mass spectrometer (Sciex, Framingham, 
MA, USA) coupled to an Eksigent nanoLC AS-2/2Dplus system, in data dependent mode, to achieve in depth 
identification of proteins. Additionally 1 μg of peptides from each individually digested sample (set 2) were com-
bined and also analysed in data dependent mode. Prior to mass spectrometric analysis, reference iRT peptides 
(Biognosys, Schlieren, Switzerland) were added to each sample according to the manufacturer’s specifications to 
allow correction of retention times. The samples were loaded in loading buffer (2% MeCN, 0.05% trifluoroacetic 
acid) and bound to an Acclaim Pepmap 100 µm × 2 cm trap (Thermo Fisher Scientific), and washed for 10 min to 
waste, after which the trap was turned in-line with the analytical column (Acclaim Pepmap RSLC 75 µm × 15 cm). 
The analytical solvent system consisted of Buffer A (2% MeCN, 0.1% FA in water) and Buffer B (2% water, 0.1% 
FA in MeCN) at a flow rate of 300 nl/min, with the following gradient: linear 1–20% of Buffer B over 90 min, lin-
ear 20–40% of Buffer B over 30 min, linear 40–99% of Buffer B over 10 min, isocratic 99% of Buffer B for 5 min, 
linear 99–1% of buffer B over 2.5 min and isocratic 1% solvent buffer B for 12.5 min. The mass spectrometer was 
operated in data-dependent analysis (DDA) top 20 positive ion mode, with 250 and 150 ms acquisition time for 
the MS1 (m/z 400–1200) and MS2 (m/z 230–1800) scans respectively, and 15 s dynamic exclusion. Rolling colli-
sion energy with a collision energy spread of 5 eV was used for fragmentation. One search result was generated 
from raw.wiff files, by merging the combined sample’s DDA data, 7 SCX fractions and 10 high pH reversed phase 
DDA data, using Protein Pilot v5.0.1 (Sciex) with the following search parameters: urea denaturation as special 
factors, trypsin as the cleavage enzyme (/K-\P and /R-\P) and carbamidomethylation as a fixed modification of 
cysteines. Within the TripleTOF 5600+ instrument setting option, MS tolerance was pre-set to 0.05 Da and MS/
MS tolerance to 0.1 Da. The search was carried out in “rapid ID” mode with a detected protein threshold of 1% 
plus false discovery rate analysis against the SwissProt database downloaded June 2015, containing only proteins 
from humans (40408 proteins). Note that the iRT peptides were included in this database.
SWATH-MS data acquisition. For SWATH-MS data acquisition, the same mass spectrometer and LC-MS/
MS setup was used essentially as described above, but operated in SWATH mode. The method uses 50 windows 
of variable Da effective isolation width with a 1 Da overlap using Sciex Variable Window Calculator tool. Each 
window has a dwell time of 150 ms to cover the mass range of 400–1250 m/z in TOF-MS mode and MS/MS data is 
acquired over a range of 230–1800 m/z with high sensitivity setting and a dwell time of 70 ms, resulting in a cycle 
time of 3.6 s. The collision energy for each window was set using the collision energy of a 2+ ion centred in the 
middle of the window with a spread of 5 eV.
Data processing and availability. Identified proteins within Protein Pilot with a 1% FDR were imported 
into Skyline Daily 4.1.1.1172538 for spectral library generation. SWATH-MS results were mapped against this 
library. Skyline parameters were chosen as follows: Peptide settings (trypsin digestion with 1 missed cleavage, 
human as background proteome, carbamidomethylation (C) and oxidation (M) as modifications); Transition set-
tings (2+ and 3+ precursor charges, 1+ and 2+ ion charges, b and y ions and precursor. Six transitions were selected 
per peptide. Final peak area was normalized based on the median value and then processed using statistical tests 
in skyline software (student’s t-test for p-value and Benjamini Hochberg method for adjusted p-value/q-value). 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the 
PRIDE39 partner repository with the dataset identifier PXD008898.
Protein synthesis assay. Quantification of newly synthesized proteins was performed using the Click-iT 
HPG assay kit (Thermo Scientific). MoDCs were transferred to clear bottom 96-well cell culture plates at 105 
cells/well and treated with 100 ng/ml of LPS for up to 24 h. The assay was then performed according to man-
ufacturer’s instruction using RPMI L-methionine-free medium as a solvent for kit components. As a nega-
tive control, cells were treated with 35 µM cyclohexamide for up to 24 h. In summary, a methionine analogue, 
L-homopropargylglycine (HPG) is added to the culture media and incorporated into proteins during active pro-
tein synthesis. For detection of the incorporated amino acid Alexa Fluor 488 azide was used, which reacts with 
the alkyne-modified protein in a chemo-selective manner. For cell quantification, nuclear staining using the HCS 
Nuclear Mask Blue Stain (Thermo Scientific) was utilised.
Western blotting. MoDCs were cultured on 12-well plates and stimulated with 100 ng/ml of LPS for up to 
24 h. Non-adherent cells were isolated and lysed, and the remaining adherent cells were washed twice with PBS, 
followed by the addition of 200 μl of RIPA (radioimmunoprecipitation assay) buffer (Cell Signaling Technology, 
Danvers, MA, USA). Cells were scraped and then lysed for an additional 10 min, at 4 °C, and pooled with the 
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non-adherent lysates. The lysates were centrifuged at 20,000 × g for 5 mins and the resultant supernatants meas-
ured using the BCA assay. The samples were then suspended in reducing buffer and denatured for 60 min at 
60 °C. Proteins were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and then finally 
transferred to Immobilon-P PVDF membranes (Millipore, Hertfordshire, UK: cat no. IPVH00010). After trans-
fer, the membranes were blocked in LiCor Blocking Buffer (diluted 50:50 in PBS) for 1 h at room temperature 
before incubating with primary antibodies overnight at 4 °C. Antibodies used were as follows: MHC I (HC10, 
anti-HLA-B/C, used at 1:1000), MHC II (Abcam, Cambridge, UK; ab157210, used at 1:1000) and β-actin (Santa 
Cruz, sc-47778; used at 1:1000), GAPDH (Santa Cruz sc-47724, used at 1:1000). Detection was then carried out 
by first washing membranes in PBS containing 0.1% Tween20 (PBST; 3 × 5 min) followed by a 45 min incuba-
tion at room temperature with IRDye800cw-labeled goat anti-mouse or -rabbit IgG secondary antibody (Li-Cor 
Biosciences, Cambridge, UK) at 1:10,000 dilution in PBST. After further washing with and PBS (1 × 5 min), visu-
alization was carried out using a LiCor Odyssey Scanner (Li-Cor Biosciences).
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